CMTM6 and neoplasm: Th1, Tfh, Th17, and M1 in OV also forecasted favorable prognosis (Dobrzanski et al., 2009; Crotty, 2019; Travers et al., 2019; Block et al., 2020), and the study suggested that CMTM6 might recruit and regulate T cell and macrophage function to affect tumor regression in OV.